Inogen | INGN - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Abbott USD 42M 2M 2025-12
Accuray USD 2.88M 72K 2024-12
AngioDynamics USD 102K 2K 2025-09
Artivion USD 5.53M 589K 2025-12
AtriCure USD 1.33M 17K 2025-09
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 3M 2025-12
Chart Industries USD 77.1M 1.2M 2025-09
Cooper Companies USD 22.4M 2M 2025-12
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 38.6M 1.2M 2025-09
Globus Medical USD 17K 5.1B 2025-12
Inogen 1.03M 384K 2025-03
Insulet USD 9.2M 2.2M 2025-12
Masimo USD 7.5M 1.3M 2025-12
Medtronic USD 181M 0 2025-12
Orthofix International 4.68M 731K 2025-09
Philips EUR 109M 31M 2025-12
ResMed USD 8.79M 14.55M 2025-09
Steris USD 14.9M 0 2025-12
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12